Trials / Conditions / Hunter Syndrome (MPS II)
Hunter Syndrome (MPS II)
3 registered clinical trials studyying Hunter Syndrome (MPS II).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome) NCT07236606 | REGENXBIO Inc. | Phase 3 |
| Completed | An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta) NCT07344376 | GC Biopharma Corp | Phase 3 |
| Terminated | Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders NCT01372228 | Talaris Therapeutics Inc. | Phase 1 / Phase 2 |